Search





Search





Pfizer Inc

PFE

Add to Watchlist

26.760USD

+0.545+2.08%

Close 08-07 16:00（ET）Quotes delayed by 15 min

152.52BMarket Cap

20.32P/E TTM

Pfizer Inc

26.760

+0.545+2.08%

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

PFE Analysis

Review the valuation, outlook, chart signals and key risks shaping Pfizer Inc stock.

China Adds Eli Lilly and Pfizer to Its First Private Insurance List — Is This a Buying Opportunity for Biotech Investors?

China Adds Eli Lilly and Pfizer to Its First Private Insurance List — Is This a Buying Opportunity for Biotech Investors?

TradingKey - China officially unveiled its first list of innovative drugs covered by commercial health insurance on December 7, greenlighting 19 high-priced therapies previously excluded from the National Reimbursement Drug List (NRDL).

TradingKeyMon, Dec 8

The Strategic Repositioning Driving Pfizer's Growth Story

The Strategic Repositioning Driving Pfizer's Growth Story

TradingKey - Pfizer’s non-COVID portfolio grew 12% in 2024, led by a 65% surge in Vyndaqel sales and 26% oncology revenue growth.

TradingKeyApr 8, 2025